NYSE:STESteris Stock Price, Forecast & News

$165.89

+3.08 (+1.89 %)

(As of 05/29/2020 04:00 PM ET)

Add

Compare

Today's Range

$161.14

Now: $165.89▼

$166.39

50-Day Range

$139.54

MA: $150.98▼

$162.81

52-Week Range

$105.69

Now: $165.89▼

$168.98

Volume720,009 shs

Average Volume601,096 shs

Market Capitalization$14.07 billion

P/E Ratio34.78

Dividend Yield0.89%

Beta0.75

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment install, maintain, upgrade, repair, and troubleshoot services. This segment provides its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting and outsourced sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier products, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide and hydrogen peroxide; and laboratory testing services. It operates a network of approximately 50 facilities. The company was founded in 1985 and is based in Derby, the United Kingdom.

Beat the Market (BTM) Rank^™

1.5 Analyst's Opinion

Consensus Rating
Steris has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $170.00, Steris has a potential upside of 2.5% from its current price of $165.89.
Amount of Analyst Coverage
Steris has only been the subject of 1 research reports in the past 90 days.

2.1 Community Rank

Outperform Votes
Steris has received 276 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Steris has received 380 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Steris has received 57.93% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Steris and other stocks. Vote “Outperform” if you believe STE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe STE will underperform the S&P 500 over the long term. You may vote once every thirty days.

5.0 Dividend Strength

Dividend Leadership
Steris is a leading dividend payer. It pays a dividend yield of 0.89%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Steris has been increasing its dividend for 10 years.
Dividend Coverage
The dividend payout ratio of Steris is 26.24 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Steris will have a dividend payout ratio of 24.14 % next year. This indicates that Steris will be able to sustain or increase its dividend.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Steris insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.36% of the stock of Steris is held by insiders.
Percentage Held by Institutions
88.05% of the stock of Steris is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Steris are expected to grow by 8.11% in the coming year, from $5.67 to $6.13 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Steris is 34.78, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 13.36.
Price to Earnings Ratio vs. Sector
The P/E ratio of Steris is 34.78, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 14.06.
Price to Book Value per Share Ratio
Steris has a P/B Ratio of 4.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.05 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Surgical appliances & supplies

Sub-IndustryHealth Care Equipment

SectorMedical

Current SymbolNYSE:STE

Previous Symbol

CUSIP85915210

CIK1624899

Webwww.steris.com

Phone353-1232-2000

Debt

Debt-to-Equity Ratio0.34

Current Ratio2.40

Quick Ratio1.91

Price-To-Earnings

Trailing P/E Ratio34.78

Forward P/E Ratio29.26

P/E GrowthN/A

Sales & Book Value

Annual Sales$3.03 billion

Price / Sales4.64

Cash Flow$6.96 per share

Price / Cash Flow23.82

Book Value$40.17 per share

Price / Book4.13

Profitability

EPS (Most Recent Fiscal Year)$5.64

Net Income$407.61 million

Net Margins13.45%

Return on Equity16.34%

Return on Assets9.12%

Miscellaneous

Employees12,000

Outstanding Shares84,810,000

Market Cap$14.07 billion

Next Earnings Date8/3/2020 (Estimated)

OptionableOptionable

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

Steris (NYSE:STE) Frequently Asked Questions

How has Steris' stock been impacted by COVID-19 (Coronavirus)?

Steris' stock was trading at $145.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, STE stock has increased by 14.2% and is now trading at $165.89. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Steris?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Steris.

When is Steris' next earnings date?

Steris is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Steris.

How were Steris' earnings last quarter?

Steris PLC (NYSE:STE) released its quarterly earnings data on Wednesday, May, 13th. The medical equipment provider reported $1.64 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.57 by $0.07. The medical equipment provider earned $822.99 million during the quarter, compared to the consensus estimate of $788.37 million. Steris had a return on equity of 16.34% and a net margin of 13.45%. During the same quarter last year, the company posted $1.53 EPS. View Steris' earnings history.

How often does Steris pay dividends? What is the dividend yield for Steris?

Steris announced a quarterly dividend on Wednesday, May 13th. Investors of record on Friday, June 12th will be given a dividend of $0.37 per share on Friday, June 26th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 0.89%. The ex-dividend date is Thursday, June 11th. View Steris' dividend history.

What price target have analysts set for STE?

2 brokers have issued twelve-month price objectives for Steris' stock. Their forecasts range from $170.00 to $170.00. On average, they anticipate Steris' stock price to reach $170.00 in the next twelve months. This suggests a possible upside of 2.5% from the stock's current price. View analysts' price targets for Steris.

Has Steris been receiving favorable news coverage?

News articles about STE stock have trended somewhat positive this week, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Steris earned a news sentiment score of 2.0 on InfoTrie's scale. They also assigned media coverage about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutSteris.

Are investors shorting Steris?

Steris saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 1,510,000 shares, a drop of 12.2% from the April 30th total of 1,720,000 shares. Based on an average daily trading volume, of 826,800 shares, the days-to-cover ratio is presently 1.8 days. Currently, 1.8% of the company's stock are sold short. View Steris' Current Options Chain.

Who are some of Steris' key competitors?

Some companies that are related to Steris include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Masimo (MASI) and Insulet (PODD). View all competitors.

What other stocks do shareholders of Steris own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Pfizer (PFE), AbbVie (ABBV), Home Depot (HD), Mastercard (MA), AT&T (T), Abbott Laboratories (ABT), Cisco Systems (CSCO), Gilead Sciences (GILD) and Mcdonald's (MCD).

Who are Steris' key executives?

Steris' management team includes the following people:

Mr. Walter M. Rosebrough Jr., CEO & Pres (Age 65)
Mr. Michael J. Tokich, Sr. VP, CFO & Director (Age 50)
Mr. Daniel A. Carestio, Chief Operating Officer (Age 46)
Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. & Director (Age 52)
Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 49)

What is Steris' stock symbol?

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are Steris' major shareholders?

Steris' stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.84%), WCM Investment Management LLC (5.99%), Janus Henderson Group PLC (5.60%), State Street Corp (4.33%), Wellington Management Group LLP (2.43%) and Massachusetts Financial Services Co. MA (2.39%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View institutional ownership trends for Steris.

Which institutional investors are selling Steris stock?

STE stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Janus Henderson Group PLC, Wellington Management Group LLP, Frontier Capital Management Co. LLC, Fiera Capital Corp, Two Sigma Investments LP, Paloma Partners Management Co, and Schroder Investment Management Group. Company insiders that have sold Steris company stock in the last year include Cary L Majors, Daniel A Carestio, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, and Walter M Rosebrough Jr. View insider buying and selling activity for Steris.

Which institutional investors are buying Steris stock?

STE stock was bought by a variety of institutional investors in the last quarter, including WCM Investment Management LLC, Alta Capital Management LLC, Franklin Resources Inc., Los Angeles Capital Management & Equity Research Inc., BlackRock Inc., William Blair Investment Management LLC, Kornitzer Capital Management Inc. KS, and AXA. View insider buying and selling activity for Steris.

How do I buy shares of Steris?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Steris' stock price today?

One share of STE stock can currently be purchased for approximately $165.89.

How big of a company is Steris?

Steris has a market capitalization of $14.07 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. Steris employs 12,000 workers across the globe.

What is Steris' official website?

The official website for Steris is www.steris.com.

How can I contact Steris?

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]

This page was last updated on 5/31/2020 by MarketBeat.com Staff